Walleye Capital
CL icon

Walleye Capital’s Colgate-Palmolive CL Stock Holding History

Walleye Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Sell
19,300
-32,300
-63% -$2.83M 0.01% 1620
2026
Q1 		$4.4M Buy
51,600
+10,000
+24% +$891K 0.02% 885
2025
Q4 		$3.29M Buy
41,600
+8,700
+26% +$682K 0.01% 1465
2025
Q3 		$2.63M Sell
32,900
-24,400
-43% -$2.08M 0.01% 1374
2025
Q2 		$5.21M Sell
57,300
-100
-0.2% -$9.13K 0.02% 845
2025
Q1 		$5.38M Buy
57,400
+10,900
+23% +$976K 0.02% 736
2024
Q4 		$4.23M Sell
46,500
-40,600
-47% -$3.87M 0.01% 1195
2024
Q3 		$9.04M Sell
87,100
-65,200
-43% -$6.65M 0.02% 749
2024
Q2 		$14.8M Sell
152,300
-22,500
-13% -$2.08M 0.03% 523
2024
Q1 		$15.7M Buy
174,800
+44,500
+34% +$3.77M 0.03% 554
2023
Q4 		$10.4M Buy
130,300
+46,600
+56% +$3.5M 0.02% 650
2023
Q3 		$5.95M Buy
83,700
+29,700
+55% +$2.22M 0.02% 907
2023
Q2 		$4.16M Buy
54,000
+43,700
+424% +$3.38M 0.02% 851
2023
Q1 		$774K Buy
+10,300
New +$766K 0.01% 1349

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Walleye Capital's CL Position: Q2 2026 in Review

Walleye Capital reduced its Colgate-Palmolive (CL) stake by 98% in Q2 2026, selling an estimated $7.57M and leaving 1,468 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

Walleye Capital first reported a position in CL in Q4 2021 and has held it in 14 quarters since. The position peaked at $23.2M in Q2 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Walleye Capital held 1,468 shares of Colgate-Palmolive worth $135K as of Q2 2026.
  • Walleye Capital sold 86,540 Colgate-Palmolive shares in Q2 2026, an estimated $7.57M.
  • Colgate-Palmolive made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3723 holding.
  • Walleye Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 14 quarters since.
  • Walleye Capital's Colgate-Palmolive position peaked at $23.2M in Q2 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.